Page 8 - Forefront Analytics News Today

Forefront Analytics LLC raised its position in shares of iShares MBS ETF (NASDAQ:MBB – Free Report) by 20.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,623 shares of the company’s stock after purchasing an additional 3,783 shares during the quarter. iShares MBS […]

Forefront Analytics LLC acquired a new stake in shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 13,769 shares of the company’s stock, valued at approximately $66,000. Several other institutional investors and hedge funds […]

Forefront Analytics LLC reduced its holdings in shares of iShares MSCI USA Momentum Factor ETF (BATS:MTUM – Free Report) by 11.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 85,406 shares of the company’s stock after selling 10,872 shares during […]

Forefront Analytics LLC raised its position in shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO – Free Report) by 10.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 407,309 shares of the exchange traded fund’s stock after buying an additional […]

Annexon, Inc. (NASDAQ:ANNX – Get Free Report) Director Muneer A. Satter bought 350,000 shares of the stock in a transaction that occurred on Tuesday, December 26th. The shares were purchased at an average price of $2.88 per share, with a total value of $1,008,000.00. Following the purchase, the director now owns 7,406,024 shares of the […]

Fusion Pharmaceuticals (NASDAQ:FUSN – Get Free Report) was upgraded by analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a research note issued on Wednesday, Marketbeat reports. The brokerage presently has a $15.00 price target on the stock, up from their previous price target of $12.00. Raymond James’ price target indicates […]

Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report)’s stock price shot up 1.8% during trading on Monday . The company traded as high as $0.85 and last traded at $0.84. 151,863 shares changed hands during trading, a decline of 10% from the average session volume of 167,858 shares. The stock had previously closed at $0.82. […]

StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research report sent to investors on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, Citigroup dropped their price objective on Eiger BioPharmaceuticals from $4.00 to $3.00 and set a buy rating on the stock in […]

The Manufacturers Life Insurance Company increased its stake in Vanguard Emerging Markets Government Bond ETF (NASDAQ:VWOB – Free Report) by 0.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,976,545 shares of the company’s stock after purchasing an additional 18,009 shares during the […]

Annexon (NASDAQ:ANNX – Get Free Report) had its target price lowered by investment analysts at Needham & Company LLC from $24.00 to $16.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. ANNX has been the subject of several other research reports. Wells Fargo […]